SEC Form 4 · accession 0001645627-17-000071
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
May 25, 2017
Accepted (ET)
May 26, 2017 · 12:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 25, 2017 | P | 1,000 | $0.059 | A | 20,987,249 | D | |
| Common Stock | May 25, 2017 | P | 1,000 | $0.0586 | A | 20,988,249 | D | |
| Common Stock | May 25, 2017 | P | 1,000 | $0.0588 | A | 20,989,249 | D | |
| Common Stock | May 25, 2017 | P | 1,000 | $0.06 | A | 20,990,249 | D | |
| Common Stock | May 25, 2017 | P | 1,000 | $0.062 | A | 20,991,249 | D | |
| Common Stock | May 25, 2017 | P | 1,000 | $0.061 | A | 20,992,249 | D | |
| Common Stock | May 25, 2017 | P | 1,000 | $0.061 | A | 20,993,249 | D | |
| Common Stock | May 25, 2017 | P | 1,000 | $0.0644 | A | 20,994,249 | D | |
| Common Stock | May 25, 2017 | P | 1,000 | $0.0649 | A | 20,995,249 | D | |
| Common Stock | May 25, 2017 | P | 1,000 | $0.0649 | A | 20,996,249 | D | |
| Common Stock | May 25, 2017 | P | 1,000 | $0.064 | A | 20,997,249 | D | |
| Common Stock | May 25, 2017 | P | 1,000 | $0.064 | A | 20,998,249 | D | |
| Common Stock | May 25, 2017 | P | 1,000 | $0.0628 | A | 20,999,249 | D | |
| Common Stock | May 25, 2017 | P | 1,000 | $0.063 | A | 21,000,249 | D |
Table II — derivative securities
No Table II lines on this filing.